Immunopathogenesis of human schistosomiasis

Area of Science:

• Immunology
• Parasitology
• Pathology

Background:

• Schistosomiasis is a major global parasitic disease causing significant morbidity and mortality.
• The disease affects hepatointestinal and genitourinary systems, with complex immunopathological features.
• Animal models have been crucial in elucidating the immune responses involved.

Purpose of the Study:

• To review the pathology and clinical outcomes of schistosomiasis.
• To provide insight into the immunopathogenesis and genetic control of human schistosomiasis.
• To explore potential anti-pathology vaccine development and broader applications for fibrotic diseases.

Main Methods:

• Review of existing literature on schistosomiasis pathology and immunopathogenesis.
• Analysis of studies utilizing animal models (e.g., murine schistosomiasis).
• Examination of cellular and molecular mechanisms, including cytokine involvement (IL-4, IL-13, IL-10) and regulatory T-cells.

Main Results:

• Hepatic pathology in murine schistosomiasis is driven by a CD4(+) T-helper 2 (Th2) granulomatous response to schistosome eggs.
• Key cytokines (IL-4, IL-13) promote pathology, while others (IL-10, IFN-gamma) and regulatory T-cells limit it.
• Hepatic stellate cells, alternatively activated macrophages, and regulatory T-cells are implicated in pathogenesis, with likely similar mechanisms in humans.

Conclusions:

• The immunopathogenesis of human schistosomiasis likely mirrors findings in animal models, involving Th2-driven responses and regulatory mechanisms.
• Understanding these mechanisms is vital for developing anti-pathology vaccines against schistosomiasis.
• Insights gained may also inform strategies for treating other granulofibrotic diseases like Crohn's disease and sarcoidosis.